Biotechnology
PGEN
1.52
price down icon16.94%   -0.31
pre-market  Vorhandelsmarkt:  1.54   0.02   +1.32%

Precigen Inc (PGEN)
full-star
loading
Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose
Schlusskurs vom Vortag:
$1.83
Offen:
$1.74
24-Stunden-Volumen:
9.20M
Relative Volume:
4.76
Marktkapitalisierung:
$448.67M
Einnahmen:
$6.23M
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-3.8974
EPS:
-0.39
Netto-Cashflow:
$-68.47M
1W Leistung:
-17.84%
1M Leistung:
+4.83%
6M Leistung:
+34.51%
1J Leistung:
-5.30%
1-Tages-Spanne:
Value
$1.47
$1.74
1-Wochen-Bereich:
Value
$1.47
$1.95
52-Wochen-Spanne:
Value
$0.6513
$2.17

Precigen Inc Stock (PGEN) Company Profile

Name
Firmenname
Precigen Inc
Name
Sektor
Healthcare (1161)
Name
Branche
Biotechnology (653)
Name
Telefon
301-556-9900
Name
Adresse
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Name
Mitarbeiter
25
Name
Twitter
@precigen
Name
Nächster Verdiensttermin
2025-03-19
Name
Neueste SEC-Einreichungen
Name
PGEN's Discussions on Twitter

Vergleichen Sie PGEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PGEN
Precigen Inc
 1.52 546.08M 6.23M -95.90M -68.47M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
 571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
 295.59 29.19B 3.81B -644.79M -669.77M -6.24

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-03-22 Herabstufung JP Morgan Neutral → Underweight
2023-05-23 Eingeleitet JP Morgan Neutral
2022-11-18 Eingeleitet Cantor Fitzgerald Overweight
2021-02-25 Eingeleitet Stifel Buy
2021-02-22 Eingeleitet Wells Fargo Overweight
2021-02-18 Eingeleitet B. Riley Securities Buy
2020-05-08 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Precigen Inc Aktie (PGEN) Neueste Nachrichten

pulisher
03:09 AM

Is Precigen Inc. a good long term investmentFree Capital Allocation Plans - jammulinksnews.com

03:09 AM
pulisher
01:54 AM

What drives Precigen Inc. stock priceSky-high profits - Autocar Professional

01:54 AM
pulisher
01:07 AM

What analysts say about Precigen Inc. stockConsistent double returns - Autocar Professional

01:07 AM
pulisher
Jul 22, 2025

Why Did Precigen Plunge 11.48%? - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Precigen Inc. Stock Analysis and ForecastSignificant capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Private Equity Firms Who Have a Significant Stake Must Be Disappointed Along With Institutions After Precigen, Inc.'s (NASDAQ:PGEN) Market Cap Dropped by US$56m - 富途牛牛

Jul 21, 2025
pulisher
Jul 16, 2025

HC Wainwright Predicts Precigen’s Q1 Earnings (NASDAQ:PGEN) - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Precigen Inc. stock price move sharplyDaily Price Surge List - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Precigen Inc. stock attracts strong analyst attentionFree Smart Money Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Precigen Inc. stock performs during market volatilityMoney Making Low Risk Plans - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Precigen (NASDAQ:PGEN) Upgraded at Wall Street Zen - Defense World

Jul 12, 2025
pulisher
Jul 10, 2025

Precigen shares rise 7.37% in premarket after FDA sets priority review date for PRGN-2012. - AInvest

Jul 10, 2025
pulisher
Jul 09, 2025

Precigen shares rise 2.11% in after-hours after FDA sets priority review date for PRGN-2012. - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

Precigen Inc (NASDAQ: PGEN) Up 15.99% This Year: What To Expect Next - Stocksregister

Jul 08, 2025
pulisher
Jul 07, 2025

Precigen's PRGN-2012: A Rare Disease Breakthrough Awaits FDA Decision in August 2025 - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

Precigen: August Is Pivotal For This Biotech Innovator - Seeking Alpha

Jul 07, 2025
pulisher
Jul 01, 2025

Precigen Announces Key Approvals at Annual Meeting - The Globe and Mail

Jul 01, 2025
pulisher
Jun 25, 2025

Precigen chief commercial officer: How AI is impacting rare disease marketing - Medical Marketing and Media

Jun 25, 2025
pulisher
Jun 18, 2025

Closing Strong: Precigen Inc (PGEN) Ends at 1.42, Down -7.79 from Last Close - DWinneX

Jun 18, 2025
pulisher
Jun 16, 2025

High Growth Tech Stocks To Watch In The US June 2025 - simplywall.st

Jun 16, 2025
pulisher
Jun 15, 2025

Bank of America Corp DE Has $232,000 Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Precigen stock price target maintained at $6 by JMP on RRP therapy - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 13, 2025

Precigen’s SWOT analysis: gene therapy firm’s stock poised for potential breakthrough - Investing.com Australia

Jun 13, 2025
pulisher
Jun 13, 2025

Precigen (NASDAQ:PGEN) Given “Market Outperform” Rating at JMP Securities - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

JMP Securities Reiterates PGEN with Market Outperform Rating | P - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

JMP Securities Reiterates PGEN with Market Outperform Rating | PGEN Stock News - GuruFocus

Jun 12, 2025

Finanzdaten der Precigen Inc-Aktie (PGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie PGEN

biotechnology GMAB
$21.80
price up icon 0.51%
biotechnology RPRX
$36.10
price up icon 1.26%
biotechnology INSM
$102.92
price up icon 0.14%
biotechnology SMMT
$26.54
price up icon 0.76%
biotechnology BNTX
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):